Search

Your search keyword '"Pilar, Zamora"' showing total 348 results

Search Constraints

Start Over You searched for: Author "Pilar, Zamora" Remove constraint Author: "Pilar, Zamora"
348 results on '"Pilar, Zamora"'

Search Results

1. Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 study

2. Diversidad y estructura genética de Lobelia villaregalis (Campanulaceae), especie en peligro endémica de Jalisco, México

3. Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer

4. Two chloroplast genomes with reduced inverted repeat regions in Mammillaria series Stylothelae (Cactaceae)

5. Metabarcoding the Bacterial Assemblages Associated with Toxopneustes roseus in the Mexican Central Pacific

6. A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry

7. Characterization of the plastome of Physalis cordata and comparative analysis of eight species of Physalis sensu stricto

8. Taxonomic revision of Physalis in Mexico

12. Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

13. Correction: Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation

14. Tiflotecnologías para el alumnado con discapacidad visual

15. Extinction risk of Mesoamerican crop wild relatives

16. Filogeografía de Tigridia durangensis (Tigridieae: Iridaceae), una especie endémica de la Zona de Transición Mexicana

17. Synergistic effect of antimetabolic and chemotherapy drugs in triple-negative breast cancer

18. ATTITUDES, MOTIVES AND INTERESTS FOR PRACTISING PHYSICAL EXERCISE

19. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry.

20. Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancer

21. Cardiac monitoring during trastuzumab therapy in metastatic breast cancer: early incidence of cardiac dysfunction

22. Metabarcoding of the phytotelmata of Pseudalcantarea grandis (Bromeliaceae) from an arid zone

23. Prediction of breast cancer risk based on profiling with common genetic variants.

24. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.

26. Abstract P4-07-29: Olaparib plus Trastuzumab in HER2[+] BRCA-Mutated Advanced Breast Cancer Patients: The OPHELIA Study

27. 806 Changes in T cell clonality in AWARE-1 study, a window-of-opportunity study with atezolizumab and the oncolytic virus pelareorep in early breast cancer

28. Bayesian networks established functional differences between breast cancer subtypes.

29. Complete sequence of wild Physalis philadelphica chloroplast genome

30. POLRMT as a Novel Susceptibility Gene for Cardiotoxicity in Epirubicin Treatment of Breast Cancer Patients

31. New records and description of two new species of carideans shrimps from Bahía Santa María-La Reforma lagoon, Gulf of California, Mexico (Crustacea, Caridea, Alpheidae and Processidae)

32. Complete chloroplast genome of Physalis chenopodifolia Lam. (Solanaceae)

33. Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication

34. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

35. Supplementary Table 2 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

36. Supplementary Table 1 from Fine-Scale Mapping of the 4q24 Locus Identifies Two Independent Loci Associated with Breast Cancer Risk

37. Data from Fine-Scale Mapping of the 4q24 Locus Identifies Two Independent Loci Associated with Breast Cancer Risk

38. Supplementary Table 3 from Confirmation of 5p12 As a Susceptibility Locus for Progesterone-Receptor–Positive, Lower Grade Breast Cancer

39. Supplementary Table 2 from Confirmation of 5p12 As a Susceptibility Locus for Progesterone-Receptor–Positive, Lower Grade Breast Cancer

40. Data from Confirmation of 5p12 As a Susceptibility Locus for Progesterone-Receptor–Positive, Lower Grade Breast Cancer

41. Supplementary Table Legend from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

42. Supplementary Table 3 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

43. Data from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

44. Supplementary Table 1 from Confirmation of 5p12 As a Susceptibility Locus for Progesterone-Receptor–Positive, Lower Grade Breast Cancer

45. Supplementary Table 1 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

46. Supplementary Tables 1-13 from 19p13.1 Is a Triple-Negative–Specific Breast Cancer Susceptibility Locus

47. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

48. Abstract OT1-12-01: Solti-1804 HER2-PREDICT: Translational study of tumor samples from breast cancer patients treated with trastuzumab deruxtecan in the metastatic setting

Catalog

Books, media, physical & digital resources